| 0.2873 0.007 (2.61%) | 11-29 10:28 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.37 | 1-year : | 0.44 |
| Resists | First : | 0.31 | Second : | 0.37 |
| Pivot price | 0.26  |
|||
| Supports | First : | 0.21 | Second : | 0.18 |
| MAs | MA(5) : | 0.28  |
MA(20) : | 0.27 |
| MA(100) : | 0.34 |
MA(250) : | 0.65 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 64.9 |
D(3) : | 66.2 |
| RSI | RSI(14): 55.6 |
|||
| 52-week | High : | 2.29 | Low : | 0.17 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ KERN ] has closed below upper band by 28.9%. Bollinger Bands are 38.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.3 - 0.3 | 0.3 - 0.3 |
| Low: | 0.26 - 0.26 | 0.26 - 0.26 |
| Close: | 0.28 - 0.28 | 0.28 - 0.29 |
Akerna Corp. provides enterprise software solutions that enable regulatory compliance and inventory management in United States and Canada. The company offers MJ Platform for the cannabis, hemp, and CBD industry; and Leaf Data Systems, a government regulatory software. It also provides consulting services to cannabis industry; business intelligence, data analytics and other software related services; and Last Call Analytics, a tool for alcohol brands to analyze their retail sales analytics. In addition, the company operates seed-to-sale platform that offers tracking, reporting, and compliance tools to cannabis cultivators, processors, sellers, and clinics. Further, it provides cannabis cultivation management and compliance software; and cannabis tracking technology that offers seed-to-sale-to-self data. Akerna Corp. was founded in 2010 and is headquartered in Denver, Colorado.
Fri, 24 Nov 2023
Will Akerna Corp (KERN) Stay at the Top of the Healthcare Sector? - InvestorsObserver
Mon, 20 Nov 2023
North American Morning Briefing : Stocks Futures Steady on Rates ... - Marketscreener.com
Thu, 16 Nov 2023
Should You Hold Akerna Corp (KERN) in Drug Manufacturers - Specialty & Generic Industry? - InvestorsObserver
Mon, 30 Oct 2023
Where Does Wall Street Think Akerna Corp (KERN) Stock Will Go? - InvestorsObserver
Thu, 19 Oct 2023
Akerna Corp.'s (NASDAQ:KERN) Price Is Right But Growth Is Lacking - Yahoo Finance
Mon, 02 Oct 2023
What is Wall Street's Target Price for Akerna Corp (KERN) Stock Monday? - InvestorsObserver
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Health Information Services
|
|
| Shares Out | 10 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 19.5 (%) |
| Held by Institutions | 3.4 (%) |
| Shares Short | 86 (K) |
| Shares Short P.Month | 26 (K) |
| EPS | -2.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.12 |
| Profit Margin | 0 % |
| Operating Margin | -81 % |
| Return on Assets (ttm) | -20.3 % |
| Return on Equity (ttm) | -363 % |
| Qtrly Rev. Growth | -32 % |
| Gross Profit (p.s.) | 0.8 |
| Sales Per Share | 0.95 |
| EBITDA (p.s.) | -0.94 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -6 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | -0.13 |
| PEG Ratio | 0 |
| Price to Book value | -0.26 |
| Price to Sales | 0.29 |
| Price to Cash Flow | -0.53 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|